S. Kalstad

Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial

Kristin Kaasen Jørgensen, Inge Christoffer Olsen, Guro Løvik Goll et al. · The Lancet · 2017 · 806 citations

Pharmacy, Internal Medicine, Pharmacotherapy +11

Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study

Brigitte Michelsen, Eirik Klami Kristianslund, Joseph Sexton et al. · Annals of the Rheumatic Diseases · 2017 · 217 citations

Medicine, Clinical Sciences, Internal Medicine +17

Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000–2010

Anna‐Birgitte Aga, Elisabeth Lie, Till Uhlig et al. · Annals of the Rheumatic Diseases · 2013 · 184 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15

The role of methotrexate co-medication in TNF-inhibitor treatment in patients with psoriatic arthritis: results from 440 patients included in the NOR-DMARD study

K. M. Fagerli, Elisabeth Lie, Désirée van der Heijde et al. · Annals of the Rheumatic Diseases · 2013 · 183 citations

Medicine, Pharmacology, Pharmacotherapy +17

Switching between TNF inhibitors in psoriatic arthritis: data from the NOR-DMARD study

K. M. Fagerli, Elisabeth Lie, Désirée van der Heijde et al. · Annals of the Rheumatic Diseases · 2013 · 132 citations

Life Sciences, Immunology, Pharmacotherapy +13